PortfoliosStock ScreensStocksStockXcel

Nutriband Inc. Warrant

NTRBW | US

1.13

USD

0

0%

NTRBW | US
Loading StockChartView...

About Nutriband Inc. Warrant

Sector

Healthcare

Industry

Biotechnology

Earnings date

31/07/2024

As of date

25/03/2026

Close

1.13

Open

1.13

High

1.13

Low

1.13

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. The company has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. Nutriband Inc. was incorporated in 2016 and is headquartered in Orlando Florida.

View Less

NTRBW | US

Risk
0.0
Sharpe
-0.16
Luna's Score
43/100
Recommendation
Sell

Luna says (NTRBW | US)

What's Working

Low Market Beta (-0.4 to 0.8)

Low Debt to Equity (< 0.25)

Low Debt to Asset (< 0.2)

What's not Working

Price Below SMA10D

High 6-Month Volatility (>65%)

Microcap (<300M USD)

Weak Operating Margin (< 10%)

Declining Revenue (< 0%)

Weak Sharpe Ratio (< 0.3)

Volatility Signals

Bearish: Increased Volatility (6-month > 1-month volatility)

Risk Meter

Loading RiskMeterView...

10 days

0.0%

1 month

0.0%

3 months

88.5%

6 months

204.8%

Returns

Loading ReturnMeterView...

Fundamental Ratios

PE

-

Fwd. PE

-

Price to book

-

Debt to equity

0.02

Debt to assets

0.02

Ent. to EBITDA

-

Ent. to rev.

-

PEG

-

Other Fundamentals

EBITDA

-5.46M

MarketCap

-

MarketCap(USD)

-

Div. yield

-

Op. margin

-462.50

Erngs. growth

-

Rev. growth

-14.30

Ret. on equity

-60.41

Short ratio

-

Short perc.

-

Market Sentiment (SMA and Price signals)

Short-term: Bullish (SMA10D > SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bearish (SMA6M < SMA12M)

SMAs: Stock Price Trends

Loading MovingAverageView...

Range10D

0.43

Range1M

0.43

Range3M

0.82

Volumes: Market Activity

Volume Averages

Loading VolumeAverageView...

Rel. volume

0.17

Price X volume

122.04

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
XOMA Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred StockXOMAOBiotechnology25.4200.04%25.57121.93%
Revolution Medicines Inc. WarrantRVMDWBiotechnology1.650-5.71%n/a5.40%
Rocket Pharmaceuticals Inc. WarrantRCKTWBiotechnology0.0255032.81%n/a0.00%
ICUCWICUCWBiotechnology0.02280-14.93%n/a-45.50%
Humacyte IncHUMAWBiotechnology0.09370-0.11%n/a-63.37%
EyeGate Pharmaceuticals IncEYEGBiotechnology35.2100.28%n/a
COEPWCOEPWBiotechnology0.01470-0.68%n/a25.11%
CELUWCELUWBiotechnology0.00750-8.54%n/a127.38%

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
No data

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA-0.53-
Ent. to Revenue-3,967.00-
PE Ratio-41.03-
Price to Book-15.55-
Dividend Yield-2.20-
Std. Deviation (3M)88.5172.80Riskier
Debt to Equity0.02-1.23Expensive
Debt to Assets0.020.25Cheaper
Market Cap-3.66B-

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007